25604-13-1 Usage
Uses
Used in Pharmaceutical Industry:
4-OXO-4-(3-PYRIDYLAMINO)BUTANOIC ACID is used as a chemical intermediate for the synthesis of various drugs and therapeutic agents, particularly those intended for the treatment of neurological disorders and inflammatory diseases. Its structural features make it a key component in the development of new medications that can address these conditions more effectively.
Used in Research and Development:
In the realm of scientific research, 4-OXO-4-(3-PYRIDYLAMINO)BUTANOIC ACID serves as a valuable tool for studying biochemical pathways and the interactions between drugs and biological systems. This understanding can lead to the discovery of novel therapeutic approaches and the optimization of existing treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 25604-13-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,0 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 25604-13:
(7*2)+(6*5)+(5*6)+(4*0)+(3*4)+(2*1)+(1*3)=91
91 % 10 = 1
So 25604-13-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2O3/c12-8(3-4-9(13)14)11-7-2-1-5-10-6-7/h1-2,5-6H,3-4H2,(H,11,12)(H,13,14)
25604-13-1Relevant academic research and scientific papers
Scope and limitations of the Minisci reaction for the synthesis of aza-heterocycles
Burgin, Ryan N.,Jones, Simon,Tarbit
scheme or table, p. 6772 - 6774 (2010/04/27)
Attempts to prepare several classes of aza-heterocycles by application of the Minisci radical cyclisation reaction are described. Competing β-scission, hydrolytic cleavage and lactonisation reactions were found to be major hurdles to adopting this strategy for the synthesis of such targets.
Novel malonamide derivatives as potent κ opioid receptor agonists
Chu, Guo-Hua,Gu, Minghua,Cassel, Joel A.,Belanger, Serge,Graczyk, Thomas M.,DeHaven, Robert N.,Conway-James, Nathalie,Koblish, Michael,Little, Patrick J.,DeHaven-Hudkins, Diane L.,Dolle, Roland E.
, p. 1951 - 1955 (2008/02/02)
A novel series of malonamide derivatives was synthesized. These amides were shown to be potent and selective κ opioid receptor agonists.
Amide derivatives and methods of their use
-
Page/Page column 38, (2008/06/13)
Amide derivatives of the general formulae Ia and Ib: are disclosed. Pharmaceutical compositions containing these compounds, and methods for their use, inter alia, for treating and/or preventing gastrointestinal disorders, pain, and pruritus are also disclosed.
